Am J Transplant, Volume 21, Suppl 3 Archives - Page 136 of 139 - ATC Abstracts

2021 American Transplant Congress
Impact of Valganciclovir Prophylaxis Dosing in High Risk Cytomegalovirus Kidney and Pancreas Transplant Recipients with Delayed Graft Function
A. Gharabagi¹, J. Geyston¹, A. Agarwal², S. Rao³, A. Doyle³, J. Dann¹
¹Pharmacy, University of Virginia Health System, Charlottesville, VA, ²Transplant Surgery, University of Virginia Health System, Charlottesville, VA, ³Transplant Nephrology, University of Virginia Health System, Charlottesville, VA
*Purpose: We sought to compare outcomes of cytomegalovirus (CMV) prophylaxis in high risk CMV (donor +/recipient -) kidney and pancreas transplant recipients who received different…
2021 American Transplant Congress
Sars-cov-2 versus Non-sars-cov-2 Infection Among Solid Organ Transplant Recipients: Case Control Study
M. A. Mendoza¹, M. Raja¹, S. Anjan¹, S. C. Curel², G. Rosello³, A. Fernandez¹, A. Chandorkar⁴, C. O'Brien⁵, A. Phancao⁵, N. Sinha¹, R. Vianna¹, M. Loebe¹, C. Gaetano¹, J. Simkins¹, M. Morris¹, L. Abbo¹, J. Camargo¹, G. Guerra¹, Y. Natori¹
¹Department of Medicine, University of Miami, Miami, FL, ²Miller School of Medicine, University of Miami, Miami, FL, ³University of Miami, Miami, FL, ⁴University of Minnesota, Minneapolis, MN, ⁵Miami Transplant Institute, University of Miami, Miami, FL
*Purpose: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has been raging since the end of 2019. The clinical differences between non-SARS-CoV-2 coronavirus and SARS-CoV-2…
2021 American Transplant Congress
COVID-19 Infection in Kidney versus Non-kidney Solid Organ Transplant Recipients: A Single Center Study
J. Schaenman¹, H. Byford², T. R. Grogan³, S. Fraschilla², K. Meneses⁴, J. C. Alejos⁵, M. Rivera⁶, S. Saab⁷
¹Infectious Diseases, UCLA, Los Angeles, CA, ²Transplant Administration, UCLA, Los Angeles, CA, ³Division of General Internal Medicine and Health Services Research, UCLA, Los Angeles, CA, ⁴Liver Transplantation, UCLA, Los Angeles, CA, ⁵Pediatric Heart Transplantation, UCLA, Los Angeles, CA, ⁶Pediatric Kidney Transplantation, UCLA, Los Angeles, CA, ⁷Liver Transplantation, David Geffen School of Medicine at UCLA, Los Angeles, CA
*Purpose: The COVID-19 pandemic has caused significant morbidity and mortality in patients around the world. A significant impact has been observed in immunocompromised patients such…
2021 American Transplant Congress
Management of Asymptomatic Bacteriuria in Kidney Transplant Recipients
A. Diamond
Pharmacy, Temple University Hospital, Philadelphia, PA
*Purpose: Asymptomatic bacteriuria (ASB) is the presence of bacteriuria with no symptoms. Recent guidelines recommend against treatment of ASB in kidney transplant (KT) recipients more…
2021 American Transplant Congress
Risk Factors Associated with Multidrug Resistant Organism (MDRO) Infections in Kidney Transplant Recipients: A Single Center Experience
S. Schrank¹, J. Timpone², B. Javaid³, P. Kumar², M. Cooper³
¹Internal Medicine, MedStar Georgetown University Hospital, Washington, DC, ²Infectious Diseases and Travel Medicine, MedStar Georgetown University Hospital, Washington, DC, ³Transplant Institute, MedStar Georgetown University Hospital, Washington, DC
*Purpose: Risk factors for MDRO infections in kidney transplant recipients have previously been studied but limited to urinary tract infections. We sought to evaluate the…
2021 American Transplant Congress
Hepatitis E Diagnosis and Management After Liver, Kidney, or Heart Transplant: A Single Center Experience
M. Carter¹, M. Fitzmaurice², S. Yeddula², A. Singh², S. Nagai², S. Jafri²
¹Wayne State University School of Medicine, Detroit, MI, ²Henry Ford Health System, Detroit, MI
*Purpose: Transplant-related Hepatitis E virus (HEV) infection is a rarely recognized entity with significant clinical importance given potential for chronic hepatitis post-transplant. We evaluated HEV…
2021 American Transplant Congress
Impact of the Kidney Allocation System on Kidney Transplant Outcomes in Patients with Long Dialysis Treatment (> 10 Years)
M. Kadatz, S. Vaishnav, S. Brar, D. Chang, J. Lan, J. Gill
Medicine, Division of Nephrology, University of British Columbia, Vancouver, BC, Canada
*Purpose: Prior to the new kidney allocation system (KAS), patients treated with dialysis for > 10 years before transplantation were shown to derive a survival…
2021 American Transplant Congress
Impact of Elevated Initial Donor Creatinine on Outcomes After Transplanting Kidney from Deceased Donor with Severe AKI
L. Kodali, K. Reddy, P. Budhiraja, S. Nair, G. Mour, J. Huskey, C. Jadloweic, H. Khamash, H. Chakkera, R. Heilman
Medicine, Mayo Clinic, Arizona, Phoenix, AZ
*Purpose: Several studies have shown good outcomes with transplanting kidneys from deceased donors with AKI; however, the impact of having elevated initial donor creatinine has…
2021 American Transplant Congress
Poor Reliability of Karnofsky Performance Score in Kidney Transplant Candidates
M. R. Stedman, D. J. Watford, G. M. Chertow, J. C. Tan
Medicine, Stanford University, Palo Alto, CA
*Purpose: The Karnofsky Performance Status (KPS) Scale has been used as a proxy for frailty and as a predictor of transplant outcomes, however reliability of…
2021 American Transplant Congress
Covid-19-related Knowledge, Health Behaviors and Attitudes Towards Telemedicine and Emergency Visits in a Population of Kidney Transplant (KTx) Recipients
A. Lin, M. Saw-Aung, W. Yang, G. Udod, A. Imas, M. Markell
SUNY Downstate Health Sciences University, Brooklyn, NY
*Purpose: We explored knowledge about COVID-19 and attitudes towards emergency care and telemedicine visits in a population of inner-city KTx pts.*Methods: A telephone survey was…